The lipotoxicity component of T2D is frequently modeled by sustained treatment of insulin-secreting cells with palmitate, resulting in reduced glucose-stimulated insulin secretion (Hoppa et al., 2009; Sako and Grill, 1990). Here, INS is linked to type 2 diabetes mellitus.